SYF Synchrony Financial

CareCredit and ADA Business Resources Extend Multi-Year Exclusive Endorsement Agreement

CareCredit, a leading health, wellness and personal care credit card, will continue to be the recommended patient financing option for members of the American Dental Association under an exclusive, seven-year endorsement agreement.

The extension agreement was recently completed with ADA Business Enterprises, Inc., the for-profit subsidiary of the American Dental Association that manages endorsements through their ADA Business Resources program. The ADA has nearly 128,000 active member dentists, which represents more than 60% of active dental providers nationwide.

ADA Business Resources has recommended CareCredit to ADA member doctors since 2001 and this agreement continues to help families manage their out-of-pocket dental expenses by providing flexible financing options that may not be covered by insurance.

The availability of financing can play an integral role in a patient’s decision-making process regarding healthcare needs. A CareCredit study found that more dental patients (67%) research financing options than the procedure itself (58%). The research also showed nearly half (49%) of respondents were very likely or extremely likely to apply for or use the CareCredit credit card if the cost of dental care increased to $1,000.¹

“We are honored to have had the privilege to serve ADA members for over 15 years,” said Doug Hammond SVP, General Manager at CareCredit. “Research shows that dental patients want and need financing options, and it is our ongoing commitment to assist members and their teams by helping patients access care.”

ADA Business Resources continually evaluates the products and services they endorse against five key criteria: they must solve a proven member need, be an industry leader, hold a higher service standard, offer ADA members preferred pricing and support the ADA’s mission. This agreement signifies a long-standing relationship between CareCredit and ADA Business Resources to bring financing options to dental patients.

“For over 15 years, CareCredit has continuously served our members with extraordinary customer service, a product that helps to further treatment acceptance and a deep, long-term involvement in our community,” said Dr. James E. Mercer, Chairman, Board of Directors, ADA Business Resources.

¹Path To Purchase Research, conducted for CareCredit by Rothstein Tauber, Inc., 2014.

About CareCredit

For nearly 30 years CareCredit, from Synchrony Financial (NYSE:SYF), has helped millions of people pay for needed and desired care and health expenses. CareCredit is a health, wellness and personal care credit card accepted through a national network of more than 200,000 healthcare providers and health-focused retailers. For more information on CareCredit, call 800-300-3046 or visit www.carecredit.com. For more information about Synchrony Financial visit www.synchronyfinancial.com.

About ADA

The not-for-profit ADA is the nation's largest dental association, representing 159,000 dentist members. The premier source of oral health information, the ADA has advocated for the public's health and promoted the art and science of dentistry since 1859. The ADA's state-of-the-art research facilities develop and test dental products and materials that have advanced the practice of dentistry and made the patient experience more positive. The ADA Seal of Acceptance long has been a valuable and respected guide to consumer dental care products. The Journal of the American Dental Association (JADA) is the ADA's flagship publication and the best-read scientific journal in dentistry. For more information about the ADA, visit ADA.org. For more information on oral health, including prevention, care and treatment of dental disease, visit the ADA's consumer website MouthHealthy.org

FOR MORE INFORMATION

www.carecredit.com or Facebook.com/CareCredit or Twitter.com/CareCredit

©2016 CareCredit. All rights reserved.

EN
20/10/2016

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Synchrony Financial

Synchrony Financial: 2 directors

Two Directors at Synchrony Financial sold/sold after exercising options 21,380 shares at 65.000USD. The significance rating of the trade was 65/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directo...

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

ResearchPool Subscriptions

Get the most out of your insights

Get in touch